Lansdale, PA, United States of America

Ben E Evans

This inventor holds 44 USPTO granted patents, primarily in Benzodiazepine Derivatives. Top assignees: Merck + Co., Inc., Synaptic Pharmaceutical Corporation. Active years: 1980-2004.


% Patents Active = 97.7

Average Co-Inventor Count = 2.9

ph-index = 18

Forward Citations = 999(Granted Patents)


Location History:

  • Landsdale, PA (US) (1986 - 1989)
  • Lansdale, PA (US) (1980 - 2004)

Company Filing History:


Years Active: 1980-2004

Loading Chart...
Areas of Expertise:
Benzodiazepine Analogs
Oxytocin Antagonists
Triazolobenzodiazepines
Dihydropyrimidines
Alpha 1a Antagonists
Renin Inhibitors
Spirocyclic Compounds
Cyclic Urea Derivatives
Peptide Inhibitors
Beta-Carbolines
Heterocyclic Rings
Pain Treatment
44 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ben E Evans

Introduction: Ben E Evans, a talented inventor hailing from Lansdale, PA, has made significant contributions to the world of innovation with his creative mind and passion for problem-solving.

Latest Patents: Ben E Evans has recently been granted patents for his groundbreaking inventions in the fields of renewable energy technology and sustainable agriculture practices.

Career Highlights: Throughout his illustrious career, Ben E Evans has been recognized for his pioneering work in developing eco-friendly solutions for everyday challenges. His commitment to environmental sustainability has led to the creation of several patented inventions that have positively impacted industries worldwide.

Collaborations: Ben E Evans has collaborated with leading research institutions and universities to further his innovative projects. His partnerships with like-minded professionals have resulted in the successful development and commercialization of cutting-edge technologies.

Conclusion: Ben E Evans continues to inspire the next generation of inventors with his dedication to creating a more sustainable and efficient world through his inventive spirit and unwavering commitment to excellence.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…